Early detection and prognosis of ovarian cancer using serum YKL-40 Academic Article uri icon

Overview

MeSH Major

  • Biomarkers, Tumor
  • Glycoproteins
  • Neoplasm Recurrence, Local
  • Neoplasm Staging
  • Ovarian Neoplasms

abstract

  • YKL-40 may represent a novel marker for the detection of early-stage ovarian cancer. YKL-40 levels in early-stage patients may also predict disease recurrence and survival. The utility of YKL-40 in detection of early-stage ovarian cancer deserves further investigation.

publication date

  • December 2004

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2004.09.112

PubMed ID

  • 15310777

Additional Document Info

start page

  • 3330

end page

  • 9

volume

  • 22

number

  • 16